The use of transcutaneous Vagal Nerve Stimulation as an effective countermeasure for Simulator Adaptation Syndrome

Appl Ergon. 2023 Feb:107:103921. doi: 10.1016/j.apergo.2022.103921. Epub 2022 Oct 29.

Abstract

This research focused on investigating the effectiveness of Transcutaneous Vagal Nerve Stimulation (tVNS) as compared to Galvanic Cutaneous Stimulation (GCS) at mitigating Simulator Adaptation Syndrome (SAS). Fifty drivers (mean age = 23.04 ± 17.71 years old, twenty-two men) participated in a driving simulation experiment. The total scores of the Simulator Sickness Questionnaire, head movements (body balance index), and driving performance variables were measured under five stimulation conditions: i) baseline (no stimulation delivered), ii) sham GCS, iii) sham tVNS, iv) active GCS, and v) active tNVS. The results showed that tVNS alleviated SAS and improved driving performance variables more effectively than GCS. We conclude that GCS and tVNS have similar neurological mechanisms to reduce SAS, providing possible explanations for the greater effectiveness of tVNS. We encourage the use of tVNS to decrease SAS.

Keywords: Galvanic cutaneous stimulation; Simulator adaptation syndrome; Transcutaneous vagal nerve stimulation.

MeSH terms

  • Adaptation, Physiological
  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Head Movements
  • Humans
  • Male
  • Syndrome
  • Transcutaneous Electric Nerve Stimulation* / methods
  • Vagus Nerve Stimulation* / methods
  • Young Adult